Galapagos N.V.
Status: Publicly traded
Direct answer
Galapagos N.V. is publicly traded on NASDAQ under the ticker GLPG.
Galapagos NV functions as an integrated biopharmaceutical enterprise, concentrating its efforts on identifying, developing, and marketing a diverse range of medications aimed at critical unaddressed medical conditions. The company's comprehensive pipeline includes several significant experimental therapies. Leading this portfolio is filgotinib, a JAK1 inhibitor that is currently progressing through various clinical...
Can you invest in Galapagos N.V.?
Yes. Galapagos N.V. trades publicly on NASDAQ as GLPG.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Galapagos N.V.
Detailed equity research is provided by MarketSnap.